[Congressional Record Volume 170, Number 20 (Monday, February 5, 2024)]
[House]
[Page H395]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




                              {time}  1415
                           REIN IN BIG PHARMA

  (Mr. KHANNA asked and was given permission to address the House for 1 
minute.)
  Mr. KHANNA. Mr. Speaker, for patients with leukemia, doctors often 
prescribe Imbruvica. In 2021, Johnson & Johnson and AbbVie sold it for 
a combined $10 billion.
  Keytruda, a drug prescribed to cancer patients, netted Merck $20 
billion; and Humira, a prescription drug for arthritis, allowed AbbVie 
to rake in $21 billion. This needs to stop.
  Big Pharma is putting profits over people. They have three lobbyists 
for every one Member of Congress and have spent $370 million on 
lobbying while making excessive profits on the backs of cancer 
families.
  That is why Senator Sanders and I have a bill to rein in prescription 
drug costs, and that is why I said let's ban PAC and lobbyist money. 
Americans shouldn't pay more for their drugs than the average price 
people in other countries are paying.

                          ____________________